Circulating progenitor cells (CPCs) are an autologous source of cells that could 1 day lead to clinically significant therapeutic neovascularization in humans.
英
美
- 循环祖细胞(CPCs)是自体细胞来源的,用于临床治疗时可以在1天内引起大量新血管生成。